Cargando…
Regulating TRAIL Receptor-Induced Cell Death at the Membrane: A Deadly Discussion
The use of TRAIL/APO2L and monoclonal antibodies targeting TRAIL receptors for cancer therapy holds great promise, due to their ability to restore cancer cell sensitivity to apoptosis in association with conventional chemotherapeutic drugs in a large variety of tumors. TRAIL-induced cell death is ti...
Autores principales: | Shirley, Sarah, Morizot, Alexandre, Micheau, Olivier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3204462/ https://www.ncbi.nlm.nih.gov/pubmed/21756247 http://dx.doi.org/10.2174/157489211796957757 |
Ejemplares similares
-
TRAIL-R4 Promotes Tumor Growth and Resistance to Apoptosis in Cervical Carcinoma HeLa Cells through AKT
por: Lalaoui, Najoua, et al.
Publicado: (2011) -
Death Receptor-Induced Apoptosis Signalling Regulation by Ezrin Is Cell Type Dependent and Occurs in a DISC-Independent Manner in Colon Cancer Cells
por: Iessi, Elisabetta, et al.
Publicado: (2015) -
N-glycosylation of mouse TRAIL-R and human TRAIL-R1 enhances TRAIL-induced death
por: Dufour, Florent, et al.
Publicado: (2017) -
Epigenetic Regulation of TRAIL Signaling: Implication for Cancer Therapy
por: Elmallah, Mohammed I. Y., et al.
Publicado: (2019) -
Marine Drugs Regulating Apoptosis Induced by Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)
por: Elmallah, Mohammed I. Y., et al.
Publicado: (2015)